Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “B-Cell Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT03093168
What this trial is testing

BCMA Chimeric Antigen Receptor Expressing T Cells in Multiple Myeloma

Who this might be right for
Multiple Myeloma
The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine 10
Not applicableStudy completedNCT01110850
What this trial is testing

Direct Measurement of Leukemic Cell Turnover (Synthesis and Removal) in Patients With Chronic Lymphocytic Leukemia (CLL) Using Deuterated Water

Who this might be right for
Chronic Lymphocytic Leukemia
Northwell Health 24
Testing effectiveness (Phase 2)UnknownNCT00927797
What this trial is testing

Interventional Study on Pentostatin, Cyclophosphamide and Rituximab in Indolent B-Cell Non-Hodgkin-Lymphoma (B-NHL)

Who this might be right for
Immunocytoma/Morbus WaldenströmB-Cell Non-Hodgkin's LymphomaB-Cell Chronic Lymphocytic Leukemia
Heidelberg University 185
Not applicableStudy completedNCT00296023
What this trial is testing

Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
University of California, San Francisco 25
Testing effectiveness (Phase 2)Ended earlyNCT01914718
What this trial is testing

Dose-adjusted EPOCH-R in MYC Positive DLBCL

Who this might be right for
Diffuse Large B-cell Lymphoma
Fudan University 26
Early research (Phase 1)Looking for participantsNCT06958679
What this trial is testing

Evaluation of SYS6005 in Patients With Advanced Malignant Tumor

Who this might be right for
B-cell MalignanciesSolid Tumors
CSPC Megalith Biopharmaceutical Co.,Ltd. 132
Large-scale testing (Phase 3)UnknownNCT05351346
What this trial is testing

Genotype-guided Treatment in DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
Ruijin Hospital 1,100
Testing effectiveness (Phase 2)Study completedNCT01757288
What this trial is testing

Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients w Favorable Prognosis Inoperable Stage IIIA/B NSCLC

Who this might be right for
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
University of Texas Southwestern Medical Center 98
Testing effectiveness (Phase 2)Study completedNCT04312841
What this trial is testing

Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab

Who this might be right for
B-Cell Prolymphocytic LeukemiaChronic Lymphocytic LeukemiaPeripheral T-Cell Lymphoma+3 more
Ohio State University Comprehensive Cancer Center 6
Early research (Phase 1)Study completedNCT05560360
What this trial is testing

A Trial of DDI Between SHR1459 and Efavirenz With Healthy Subjects

Who this might be right for
B-cell Tumors
Jiangsu HengRui Medicine Co., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT02332980
What this trial is testing

Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue+20 more
Mayo Clinic 65
Testing effectiveness (Phase 2)Study completedNCT00607854
What this trial is testing

Safety of Ibritumomab Tiuxetan (Zevalin®) in Combination With a Fludarabine-based Reduced Intensity Conditioning (RIC) Regimen (ZEVALLO 2007)

Who this might be right for
Diffuse Large B-Cell LymphomaMantle Cell Lymphoma
University Hospital, Bordeaux 31
Early research (Phase 1)Study completedNCT00410982
What this trial is testing

Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies

Who this might be right for
LeukemiaLymphomaMyeloma
M.D. Anderson Cancer Center 145
Early research (Phase 1)Study completedNCT01713582
What this trial is testing

A Dose-finding Study of the Bromodomain (Brd) Inhibitor OTX015/ Birabresib (MK-8628) in Hematologic Malignancies (MK-8628-001)

Who this might be right for
Acute Myeloid LeukemiaDiffuse Large B-cell LymphomaAcute Lymphoblastic Leukemia+1 more
Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 141
Testing effectiveness (Phase 2)Study completedNCT00640523
What this trial is testing

Phase II Study of Forodesine in Subjects With Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
BioCryst Pharmaceuticals 23
Large-scale testing (Phase 3)Ended earlyNCT00500240
What this trial is testing

Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL)

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 52
Testing effectiveness (Phase 2)Study completedNCT03019640
What this trial is testing

Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Mantle Cell LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent Follicular Lymphoma+4 more
M.D. Anderson Cancer Center 22
Not applicableLooking for participantsNCT06710418
What this trial is testing

Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia

Who this might be right for
Acute Myeloid LeukemiaB Acute Lymphoblastic LeukemiaB Lymphoblastic Lymphoma+1 more
University of Washington 50
Early research (Phase 1)Study completedNCT01410513
What this trial is testing

Study Combining SAR245409 With Rituximab or Bendamustine Plus Rituximab in Patients With Indolent Lymphoma, Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia

Who this might be right for
Indolent Non-Hodgkin LymphomaMantle Cell LymphomaChronic Lymphocytic Leukemia
Sanofi 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT02846623
What this trial is testing

Atezolizumab, Obinutuzumab, and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Relapsed or Refractory Richter Syndrome

Who this might be right for
Chronic Lymphocytic LeukemiaRecurrent Transformed Chronic Lymphocytic LeukemiaRefractory Transformed Chronic Lymphocytic Leukemia+2 more
M.D. Anderson Cancer Center 50
Next Page